Medistics Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.50 M
as on 09-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.97 Cr
as on 09-12-2024
- Revenue -31.56%
(FY 2023)
- Profit -44.91%
(FY 2023)
- Ebitda -45.07%
(FY 2023)
- Net Worth 153.58%
(FY 2023)
- Total Assets -25.02%
(FY 2023)
About Medistics Global
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.97 Cr.
Dinesh Kundapur and Prema Kundapur serve as directors at the Company.
- CIN/LLPIN
U36100KA2016PTC086263
- Company No.
086263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medistics Global Private Limited offer?
Medistics Global Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Medistics Global?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Kundapur  | Director | 17-Feb-2016 | Current |
| Prema Kundapur | Director | 24-Dec-2022 | Current |
Financial Performance of Medistics Global.
Medistics Global Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.56% decrease. The company also saw a substantial fall in profitability, with a 44.91% decrease in profit. The company's net worth Soared by an impressive increase of 153.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medistics Global?
In 2023, Medistics Global had a public holding of 1.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tavisa Wellness Private LimitedInactive For E-Filing 9 months 23 daysDinesh Kundapur and Prema Kundapur are mutual person
- Dinesh Printers India Private LimitedActive 3 years 9 months
Dinesh Kundapur and Prema Kundapur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Dec 2017 | ₹7.97 Cr | Open |
How Many Employees Work at Medistics Global?
Unlock and access historical data on people associated with Medistics Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medistics Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medistics Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
